Research Reference · Tissue Repair Blend
BB (BPC-157 & TB-500)
A two-peptide research blend of BPC-157 and TB-500 — the pairing known in research circles as the “Wolverine” stack — studied through its components in preclinical repair models.
At a glance
BB is a research blend of two peptides — BPC-157 and TB-500, 10 mg each — the pairing known in research circles as the “Wolverine” stack. Both are among the most-studied repair peptides and are often examined together. No study of the blend itself has been published: the evidence belongs to each component and is mostly preclinical.
What it’s studied for
Tendon & soft tissue
BPC-157 increased tendon-cell outgrowth, survival and migration; reviews cover muscle, tendon and ligament models. 2,3
Cell & animalWound closure
Thymosin beta-4 sped wound closure in rats; BPC-157 has its own wound-healing literature. 5,1
AnimalBlood-vessel formation
BPC-157 activated the VEGFR2 pathway behind new vessel growth. 7
Cell & animalBB
BB (20mg) · $79.99
Third-party tested · batch-matched COA · research use only
How it works
BB combines two peptides with different, complementary roles in repair models. BPC-157 is studied for repair signaling and new blood-vessel growth through the VEGFR2 pathway, 7 and in culture it increased tendon-cell outgrowth, survival and migration. 2
TB-500 (thymosin beta-4) controls actin — the protein cells use to move — and sped wound closure in rats. 6,5
Researchers pair them to study repair signaling and cell movement in the same model. No study of the combined blend has been published, so each component’s evidence should be read on its own terms. 3,4
Related research
Frequently asked questions
What is in BB?
Why is it called the “Wolverine” stack?
Has the BB blend itself been studied?
How is BB different from GLOW and KLOW?
How is each batch verified?
Identifiers
| Components | BPC-157 (10 mg) + TB-500 (10 mg) |
|---|---|
| Total peptide | 20 mg per vial |
| BPC-157 | C62H98N16O22 · CAS 137525-51-0 · PubChem CID 9941957 |
| TB-500 | Thymosin beta-4 / its 17–23 fragment — see the TB-500 page |
| Batch testing | Each component quantified separately on the COA |
| Supplied as | Lyophilized (freeze-dried) powder |
Component identifiers checked against PubChem.
Research timeline
- 1999Thymosin beta-4 speeds wound closure in rats. 5
- 2005Review of thymosin beta-4 as an actin-binding repair protein. 6
- 2011BPC-157 increases tendon-cell outgrowth, survival and migration. 2
- 2017BPC-157’s VEGFR2 blood-vessel mechanism is described. 7
- 2019Review of BPC-157 in soft-tissue healing. 3
- 2021Reviews of BPC-157 in wound healing 1 and of thymosin beta-4. 4
Key studies
| Study | Model | What it found |
|---|---|---|
| Malinda 1999 5 | Rat + cell (Tβ4) | Faster wound closure; more skin-cell migration. |
| Chang 2011 2 | Cell (BPC-157) | More tendon-cell outgrowth, survival and migration. |
| Hsieh 2017 7 | Cell + rat (BPC-157) | VEGFR2–Akt–eNOS activation; better blood-flow recovery. |
| Gwyer 2019 3 | Review (BPC-157) | Musculoskeletal soft-tissue healing evidence and mechanisms. |
Sources
- Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Seiwerth S, et al. Front Pharmacol, 2021. Free full textReview
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Chang CH, et al. J Appl Physiol, 2011.
- Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Gwyer D, et al. Cell Tissue Res, 2019. Review
- Progress on the Function and Application of Thymosin β4. Xing Y, et al. Front Endocrinol (Lausanne), 2021. Free full textReview
- Thymosin beta4 accelerates wound healing. Malinda KM, et al. J Invest Dermatol, 1999.
- Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Goldstein AL, et al. Trends Mol Med, 2005. Review
- Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Hsieh MJ, et al. J Mol Med, 2017.
Last reviewed September 2026 by Midwest Compounds. Every source above was checked against its original publication.